Turning Point: The Quest for a Cure
BrightFocus Foundation is a presentation partner for Turning Point, an award-winning documentary capturing the drama and dedication of scientists and clinical trial volunteers who are working to make Alzheimer’s a distant memory.
Working with Gates Ventures and public and private sector leaders, BrightFocus has screened the film nationally and internationally for community audiences, health care and scientific groups, and policymakers.
“Turning Point is an excellent documentary that gives us an inside look at the doctors, scientists, and patients who are working to uncover the mysteries of Alzheimer’s disease through clinical trials. Everybody should see this film.”- Bill Gates
The Quest for an Alzheimer’s Cure
Watch Now
Rent or purchase the full documentary, Turning Point: The Quest for a Cure, on one of these trusted streaming platforms.
Funded by:
The film was funded through a grant by Eli Lilly and Company to Volunteers of America. PCH Films retained full editorial control of all content and messaging in the film.
Related Resources
Related Resources & Information
What AI Means for Alzheimer’s: 6 Things an Expert Wants You to Know
Expert insights on how artificial intelligence is transforming Alzheimer’s and dementia research and diagnosis.
How Focused Ultrasound is Changing Alzheimer’s Treatment
Join Dr. Ali R. Rezai, a leader in neuroscience and neuromodulation, for a live conversation on how focused ultrasound is opening new possibilities in Alzheimer’s research and care.
How Much Forgetfulness is Too Much?
Ronald C. Petersen, MD, PhD, discusses what we know about Alzheimer’s and how we can better understand what it is – and what it isn’t.
Financial Aid for Alzheimer’s Medications
Learn about financial aid resources that may be available to help cover the costs of your Alzheimer’s prescription medications.
Alzheimer’s Research Opportunities: How to Participate
Dr. Michelle Papka gives insights into how to participate in trials that are currently open for enrollment across the US.
New Technologies for Early Detection of Alzheimer’s
What new technologies for diagnosing cognitive disorders are on the horizon? Join Dr. Michael Weiner, a leading expert in neuroimaging and biomarkers, as he explores advancements in digital and voice assessments, MRI, PET scans, and blood-based tests.
The Path Forward in Stopping Alzheimer’s Disease
Join our conversation with Dr. Rudolph Tanzi as he explains how stopping Alzheimer’s disease will require a combination of early detection using blood biomarkers, presymptomatic intervention with safe and affordable therapies, and lifestyle modifications.
Navigating Clinical Trials for Alzheimer’s Disease
Join our conversation with Dr. Jeffrey L. Cummings, renowned expert in dementia drug development and research studies, for insights into the different types, qualification processes, and phases of studies that may be right for you or your loved one.
Environmental Pollution Can Increase Your Alzheimer’s Risk, Say BrightFocus-Funded Scientists
Urban and rural communities alike face potential long-term health consequences from environmental toxins that could lead to Alzheimer’s disease.